Literature DB >> 24164107

Non-adherence in difficult asthma and advances in detection.

John T Lindsay1, Liam G Heaney.   

Abstract

Non-adherence to anti-inflammatory therapies is common in patients referred for specialist assessment at difficult-to-treat asthma services. In the difficult asthma setting, non-adherence to treatment is associated with poor baseline asthma control, increased frequency of exacerbations and asthma-related hospitalizations, as well as increased risk of death. Here, we present a review of the current literature surrounding the prevalence and risks of non-adherence in difficult asthma and we report on current methods of measuring treatment adherence and advances in the detection of non-adherence. We will also explore methods by which non-adherence in difficult asthma can be addressed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24164107     DOI: 10.1586/17476348.2013.842129

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  9 in total

Review 1.  The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.

Authors:  Timothy E Albertson; John R Richards; Amir A Zeki
Journal:  Ther Adv Respir Dis       Date:  2015-12-14       Impact factor: 4.031

Review 2.  Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy.

Authors:  Timothy E Albertson; Samuel W Bullick; Michael Schivo; Mark E Sutter
Journal:  Drug Des Devel Ther       Date:  2016-12-14       Impact factor: 4.162

Review 3.  Managing the pediatric patient with refractory asthma: a multidisciplinary approach.

Authors:  James Cook; Fran Beresford; Valentina Fainardi; Pippa Hall; Georgie Housley; Angela Jamalzadeh; Michelle Nightingale; David Winch; Andrew Bush; Louise Fleming; Sejal Saglani
Journal:  J Asthma Allergy       Date:  2017-04-20

4.  Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children.

Authors:  Yuan Zhou; Yanming Lu; Haojin Zhu; Yanhan Zhang; Yaqin Li; Qing Yu
Journal:  Patient Prefer Adherence       Date:  2018-05-18       Impact factor: 2.711

Review 5.  Update on new biologics for intractable eosinophilic asthma: impact of reslizumab.

Authors:  Jagdeep Sahota; Douglas S Robinson
Journal:  Drug Des Devel Ther       Date:  2018-05-08       Impact factor: 4.162

Review 6.  Digital technologies and adherence in respiratory diseases: the road ahead.

Authors:  John D Blakey; Bruce G Bender; Alexandra L Dima; John Weinman; Guilherme Safioti; Richard W Costello
Journal:  Eur Respir J       Date:  2018-11-22       Impact factor: 16.671

7.  Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary Care.

Authors:  John Busby; David Price; Riyad Al-Lehebi; Sinthia Bosnic-Anticevich; Job F M van Boven; Benjamin Emmanuel; J Mark FitzGerald; Mina Gaga; Susanne Hansen; Mark Hew; Takashi Iwanaga; Désirée Larenas Linnemann; Bassam Mahboub; Patrick Mitchell; Daniela Morrone; Jonathan Pham; Celeste Porsbjerg; Nicolas Roche; Eileen Wang; Neva Eleangovan; Liam G Heaney
Journal:  J Asthma Allergy       Date:  2021-11-10

8.  A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.

Authors:  Alison Moore; Andrew Preece; Raj Sharma; Liam G Heaney; Richard W Costello; Robert A Wise; Andrea Ludwig-Sengpiel; Giselle Mosnaim; Jamie Rees; Ryan Tomlinson; Ruth Tal-Singer; David A Stempel; Neil Barnes
Journal:  Eur Respir J       Date:  2021-06-04       Impact factor: 33.795

Review 9.  Measuring adherence to therapy in airways disease.

Authors:  Joshua Holmes; Liam G Heaney
Journal:  Breathe (Sheff)       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.